Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.75 CHF | -2.86% | +0.74% | +15.44% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.44% | 553M | |
-1.78% | 41.35B | |
+42.15% | 40.38B | |
+1.96% | 39.05B | |
-14.19% | 26.67B | |
+1.70% | 24.07B | |
-23.89% | 18.36B | |
-3.87% | 11.68B | |
+21.03% | 11.6B | |
+7.45% | 11.15B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Basilea Pharmaceutica : Invasive Aspergillosis Drug Isavuconazole Accepted For Regulatory Review in China